Product Information
GRISEOFULVIN ULTRA 125 MG TAB is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $2.6518 per EA under NDC 00115172401. Its NADAC has been published 173 times since Sep 12, 2018.
FDA first approved this application on Jan 9, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
125 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115172401
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GRISEOFULVINApproval Type
Generic (ANDA)
FDA Application
ANDA204371FDA Approved
1/9/2014
TE Code
AB
On Market Since
9/29/2014
Pharmacological Classes
Price Statistics
The NADAC for GRISEOFULVIN ULTRA 125 MG TAB has been published 173 times since Sep 12, 2018, and over the history we have for it it has risen 3.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6518 per EA |
|---|---|
| All-time high | $3.3262 (Jan 14, 2026) |
| All-time low | $2.3728 (Apr 17, 2024) |
| 52-week high | $3.3262 |
| 52-week low | $2.6518 |
| Median price | $2.5791 |
| Average price | $2.7712 |
| Largest weekly change | +29.0% (May 21, 2025) |
| Weeks tracked | 173 |
| Tracking since | Sep 12, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ultramicrosize Griseofulvin Tablets market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ultramicrosize Griseofulvin Tablets market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tubulin Inhibiting Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GRISEOFULVIN ULTRA 125 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for GRISEOFULVIN ULTRA 125 MG TAB, manufactured by Amneal Pharmaceuticals of New York LLC, is $2.6518 per EA (NDC 00115172401), effective Sep 30, 2026.
How has the price of GRISEOFULVIN ULTRA 125 MG TAB changed over time?
Over the history we have for it, the NADAC for GRISEOFULVIN ULTRA 125 MG TAB has risen 3.0%. It has been tracked across 173 weekly CMS publications since Sep 12, 2018.
What are the highest and lowest recorded NADAC prices for GRISEOFULVIN ULTRA 125 MG TAB?
Since Sep 12, 2018, the NADAC for GRISEOFULVIN ULTRA 125 MG TAB has ranged from a low of $2.3728 (Apr 17, 2024) to a high of $3.3262 (Jan 14, 2026), with a median of $2.5791 per EA.
Are there cheaper alternatives to GRISEOFULVIN ULTRA 125 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of GRISEOFULVIN ULTRA 125 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GRISEOFULVIN ULTRA 125 MG TAB?
GRISEOFULVIN ULTRA 125 MG TAB (NDC 00115172401) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.